Emerging research suggest this peptide, a dual agonist targeting both the gut-brain axis and another hormone, appears to represent a promising step forward for body management . Preliminary clinical trials have indicated impressive decreases in body mass , possibly surpassing other body composition medications . Despite this, more study is necessar